Matrix Gla Protein (MGP) Peptide
MGP
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN939467
Quick Overview for Matrix Gla Protein (MGP) Peptide (ABIN939467)
Target
MGP
(Matrix Gla Protein (MGP))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- INRRNANTFI SPQQRWRAKV QERIRERSKP VHELNREACD DYRLCERYAM
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MGP antibody,
Alternative Names: MGP control peptide, MGP antibody Blocking Peptide, Anti-MGP Blocking Peptide, Matrix Gla Protein Blocking Peptide, GIG36 Blocking Peptide, MGLAP Blocking Peptide, NTI Blocking Peptide -
Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
-
Matrix Gla Protein (MGP) (AA 20-96) peptide (His tag)
MGP Reactivity: Human Host: Escherichia coli (E. coli) SDS
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- MGP (Matrix Gla Protein (MGP))
-
Background
- MGP is associates with the organic matrix of bone and cartilage. MGP is thought to act as an inhibitor of bone formation.
-
Molecular Weight
- 12 kDa
Target
-
You are here:
